Cellpro Biotech focus on infertility class research and development, production and sales of biological diagnostic reagents At this stage, the business focus on diagnostic reagents for sperm production and sales, Customer orientation in the 356 approved for reproductive center of human assisted reproductive technology. Core technology is the detection reagent stability, flow cytometry instrument data analysis model, the self-developed analysis software and a large number of sperm detection case. In May 2014, Ningbo XinYi(Infinity Group)fund, Ningbo Angel fund, Dongyuan venture capital and Ningbo Guidance fund together invested 20 million RMB. In June 2015, Ningbo XinYi(Infinity Group)fund invested extra 3 million RMB in the new round of financing. Major customers and manufacturers: The reproductive center hospital in China: Zhejiang women and Kids hospital, Shanghai Renji hospital, xiangyahospital, Reproductive Hospital Affiliated to Shandong University, Jiangsu province people's hospital, the first hospital affiliated to Wenzhou medical hospital,Gulou hospital of Jiangsu province, etc. Company Website:http://www.cellpro.cn/index.html